Drugs / STAR-0310
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06782477 | Jan 2025 → Jan 2026 overdue | — | Astria Therapeutics, Inc. | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | STAR-0310 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06782477 ↗ |
| Route | Subcutaneous | “STAR-0310 will be administered as a subcutaneous bolus injection.” NCT06782477 ↗ |